These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 9293971)
21. Angiotensin-converting enzyme inhibitors, inhibition of brain and peripheral angiotensin-converting enzymes, and left ventricular dysfunction in rats after myocardial infarction. Ahmad M; White R; Tan J; Huang BS; Leenen FH J Cardiovasc Pharmacol; 2008 Jun; 51(6):565-72. PubMed ID: 18496146 [TBL] [Abstract][Full Text] [Related]
25. Interactions of the kallikrein-kinin and renin-angiotensin systems in experimental diabetes. Vora JP; Oyama TT; Thompson MM; Anderson S Diabetes; 1997 Jan; 46(1):107-12. PubMed ID: 8971089 [TBL] [Abstract][Full Text] [Related]
26. Combination therapy with angiotensin converting enzyme inhibition and AT1 receptor inhibitor on ventricular remodeling after myocardial infarction in rats. Zornoff LA; Paiva SA; Matsubara BB; Matsubara LS; Spadaro J J Cardiovasc Pharmacol Ther; 2000 Jul; 5(3):203-9. PubMed ID: 11150409 [TBL] [Abstract][Full Text] [Related]
27. Multiple interactions between the renin-angiotensin and the kallikrein-kinin systems: role of ACE inhibition and AT1 receptor blockade. Tschöpe C; Schultheiss HP; Walther T J Cardiovasc Pharmacol; 2002 Apr; 39(4):478-87. PubMed ID: 11904521 [TBL] [Abstract][Full Text] [Related]
28. Effects of alatriopril, a mixed inhibitor of atriopeptidase and angiotensin I-converting enzyme, on cardiac hypertrophy and hormonal responses in rats with myocardial infarction. Comparison with captopril. Bralet J; Marie C; Mossiat C; Lecomte JM; Gros C; Schwartz JC J Pharmacol Exp Ther; 1994 Jul; 270(1):8-14. PubMed ID: 8035346 [TBL] [Abstract][Full Text] [Related]
29. Role of ACE inhibition or AT1 blockade in the remodeling following myocardial infarction. Holtz J Basic Res Cardiol; 1998; 93 Suppl 2():92-100. PubMed ID: 9833170 [TBL] [Abstract][Full Text] [Related]
30. Effects of captopril on interstitial collagen in the myocardium after infarction in rats. Milanez MC; Gomes MG; Vassallo DV; Mill JG J Card Fail; 1997 Sep; 3(3):189-97. PubMed ID: 9330127 [TBL] [Abstract][Full Text] [Related]
31. Effects of angiotensin-converting enzyme inhibition and bradykinin peptides in rats with myocardial infarction. Qu Z; Xu H; Tian Y Int J Clin Exp Pathol; 2015; 8(3):3410-7. PubMed ID: 26045879 [TBL] [Abstract][Full Text] [Related]
32. Effects of angiotensin II receptor blockade versus angiotensin-converting-enzyme inhibition on ventricular remodelling following myocardial infarction in the mouse. Patten RD; Aronovitz MJ; Einstein M; Lambert M; Pandian NG; Mendelsohn ME; Konstam MA Clin Sci (Lond); 2003 Feb; 104(2):109-18. PubMed ID: 12546633 [TBL] [Abstract][Full Text] [Related]
33. Role of kinins in chronic heart failure and in the therapeutic effect of ACE inhibitors in kininogen-deficient rats. Liu YH; Yang XP; Mehta D; Bulagannawar M; Scicli GM; Carretero OA Am J Physiol Heart Circ Physiol; 2000 Feb; 278(2):H507-14. PubMed ID: 10666082 [TBL] [Abstract][Full Text] [Related]
34. Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy. Tschöpe C; Seidl U; Reinecke A; Riester U; Graf K; Schultheiss HP; Hilgenfeldt U; Unger T Int Immunopharmacol; 2003 Mar; 3(3):335-44. PubMed ID: 12639811 [TBL] [Abstract][Full Text] [Related]
35. Activity and functional significance of the renal kallikrein-kinin-system in polycystic kidney disease of the rat. Braun C; Kleemann T; Hilgenfeldt U; Riester U; Rohmeiss P; van der Woude FJ Kidney Int; 2002 Jun; 61(6):2149-56. PubMed ID: 12028455 [TBL] [Abstract][Full Text] [Related]
36. Type 2 bradykinin-receptor antagonism does not modify kinin or angiotensin peptide levels. Campbell DJ; Kladis A; Briscoe TA; Zhuo J Hypertension; 1999 May; 33(5):1233-6. PubMed ID: 10334817 [TBL] [Abstract][Full Text] [Related]
37. Angiotensin-converting enzyme inhibitor enhances liver regeneration following partial hepatectomy: involvement of bradykinin B2 and angiotensin AT1 receptors. Yayama K; Sugiyama K; Miyagi R; Okamoto H Biol Pharm Bull; 2007 Mar; 30(3):591-4. PubMed ID: 17329864 [TBL] [Abstract][Full Text] [Related]
38. Interaction between neutral endopeptidase and angiotensin converting enzyme inhibition in rats with myocardial infarction: effects on cardiac hypertrophy and angiotensin and bradykinin peptide levels. Duncan AM; James GM; Anastasopoulos F; Kladis A; Briscoe TA; Campbell DJ J Pharmacol Exp Ther; 1999 Apr; 289(1):295-303. PubMed ID: 10087017 [TBL] [Abstract][Full Text] [Related]
39. Survival after myocardial infarction in the rat. Role of tissue angiotensin-converting enzyme inhibition. Wollert KC; Studer R; von Bülow B; Drexler H Circulation; 1994 Nov; 90(5):2457-67. PubMed ID: 7955203 [TBL] [Abstract][Full Text] [Related]
40. Towards understanding the kallikrein-kinin system: insights from measurement of kinin peptides. Campbell DJ Braz J Med Biol Res; 2000 Jun; 33(6):665-77. PubMed ID: 10829095 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]